Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;32(1):28-36.
doi: 10.1089/thy.2021.0356.

Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy

Affiliations

Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy

Danielli Matsuura et al. Thyroid. 2022 Jan.

Abstract

Background: The approach for surgical treatment of patients with low-/intermediate-risk T1T2N0/Nx well-differentiated thyroid cancer (WDTC)-total thyroidectomy (TT) versus thyroid lobectomy (TL)-remains a controversial topic. Conducting a randomized controlled trial (RCT) would be the gold standard to address this issue. However, this is challenging due to excellent survival outcomes, and therefore, high number of patients and long-term follow-up would be required. As an alternative to RCT, we have used propensity score (PS) matching to determine if T1T2N0/Nx patients selected to have TL had equivalent outcomes to a similar group treated with TT. Methods: After institutional review board approval, a database of 6259 patients with WDTC treated with primary surgery at our institution between 1985 and 2016 was analyzed to identify patients with T1T2N0/Nx cancers. Of 3756 patients identified, 943 were managed by TL and 2813 by TT. To control for possible confounders and reduce potential bias, we selected age, sex, histology, 131I therapy, American Thyroid Association risk, and American Joint Committee Cancer stage as our PS matching criteria. Subsequently, 918 TL patients were successfully matched with 918 TT patients. The Pearson χ2 test or Fisher's exact test was used to compare categorical covariates, and Student's t-test was used for comparison of continuous variables between the two groups. Disease-specific survival (DSS), overall survival (OS), and recurrence-free survival (RFS) were calculated using the Kaplan-Meier method and compared using the log-rank test. Results: After PS matching, there were no significant differences between TL and TT patients for OS (10-year OS: 92.2% vs. 91.3%, p = 0.9668), DSS (10-year DSS: 100% vs. 99.1%, p = 0.1967), or RFS (10-year RFS: 99.5% vs. 98.3%, p = 0.079). Conclusions: For low-/intermediate-risk patients with intrathyroidal thyroid cancer <4 cm, patients selected for TL have similar survival outcomes to a comparable group treated by TT.

Keywords: early stage; intermediate risk; lobectomy; low risk; propensity matching; thyroid cancer; total thyroidectomy.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial or personal relationships that could potentially influence this work.

Figures

FIG. 1.
FIG. 1.
CONSORT flow diagram showing the inclusion and exclusion criteria. *Staging system according to the American Joint Committee Cancer, Eighth edition. **Risk stratification according to the 2015 American Thyroid Association Guidelines. pT, pathological tumor.
FIG. 2.
FIG. 2.
The standardized mean difference in the entire cohort and the matched cohorts. This figure demonstrates that there are balanced covariates between the lobectomy and total thyroidectomy groups in the matched cohort. RAI, radioactive iodine.
FIG. 3.
FIG. 3.
Kaplan–Meier plots for overall survival stratified by surgery after propensity matching. There was no statistically significant difference between the two groups.
FIG. 4.
FIG. 4.
Kaplan–Meier plots for disease-specific survival stratified by surgery after propensity matching. There was no statistically significant difference between the two groups.
FIG. 5.
FIG. 5.
Kaplan–Meier plots for recurrence-free survival stratified by surgery after propensity matching. There was no statistically significant difference between the two groups.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. - PubMed
    1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941–1953. - PubMed
    1. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C. 2007. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381; discussion 381–384. - PMC - PubMed
    1. Haigh PI, Urbach DR, Rotstein LE. 2005. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 12:81–89. - PubMed
    1. Udelsman R, Shaha AR. 2005. Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer? Lancet Oncol 6:529–531. - PubMed

Publication types